Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 123

1.

Neoadjuvant chemotherapy can improve outcome of colorectal cancer patients with unresectable metastasis.

Shao YC, Chang YY, Lin JK, Lin CC, Wang HS, Yang SH, Jiang JK, Lan YT, Lin TC, Li AF, Chen WS, Chang SC.

Int J Colorectal Dis. 2013 Oct;28(10):1359-65. doi: 10.1007/s00384-013-1713-x. Epub 2013 May 22.

PMID:
23695387
2.

Prognostic factors for disease-free survival after preoperative chemotherapy followed by curative resection in patients with colorectal cancer harboring hepatic metastasis: a single-institute, retrospective analysis in Asia.

Yi JH, Kim H, Jung M, Shin SJ, Choi JS, Choi GH, Baik SH, Min BS, Kim NK, Ahn JB.

Oncology. 2013;85(5):283-9. doi: 10.1159/000355475. Epub 2013 Nov 6.

PMID:
24217184
3.

Survival outcomes of liver metastasectomy in colorectal cancer cases: a single-center analysis in Turkey.

Cokmert S, Ellidokuz H, Demir L, Fuzun M, Astarcioglu I, Aslan D, Yilmaz U, Oztop I.

Asian Pac J Cancer Prev. 2014;15(13):5195-200.

4.

Survival after lung metastasectomy in colorectal cancer patients with previously resected liver metastases.

Gonzalez M, Robert JH, Halkic N, Mentha G, Roth A, Perneger T, Ris HB, Gervaz P.

World J Surg. 2012 Feb;36(2):386-91. doi: 10.1007/s00268-011-1381-3.

PMID:
22167262
5.

Adjuvant systemic chemotherapy after putative curative resection of colorectal liver and lung metastases.

Brandi G, Derenzini E, Falcone A, Masi G, Loupakis F, Pietrabissa A, Pinna AD, Ercolani G, Pantaleo MA, Di Girolamo S, Grazi GL, de Rosa F, Biasco G.

Clin Colorectal Cancer. 2013 Sep;12(3):188-94. doi: 10.1016/j.clcc.2013.04.002. Epub 2013 Jun 14.

PMID:
23773458
6.

Prognostic value of perineural invasion in patients with stage II colorectal cancer.

Huh JW, Kim HR, Kim YJ.

Ann Surg Oncol. 2010 Aug;17(8):2066-72. doi: 10.1245/s10434-010-0982-7. Epub 2010 Feb 25.

PMID:
20182809
7.

FOLFOX as adjuvant chemotherapy after curative resection of distant metastases in patients with colorectal cancer.

Nozawa H, Kitayama J, Sunami E, Saito S, Kanazawa T, Kazama S, Yazawa K, Kawai K, Mori K, Nagawa H.

Oncology. 2011;80(1-2):84-91. doi: 10.1159/000328761. Epub 2011 Jun 13.

PMID:
21677451
8.

Outcome of microscopic incomplete resection (R1) of colorectal liver metastases in the era of neoadjuvant chemotherapy.

Ayez N, Lalmahomed ZS, Eggermont AM, Ijzermans JN, de Jonge J, van Montfort K, Verhoef C.

Ann Surg Oncol. 2012 May;19(5):1618-27. doi: 10.1245/s10434-011-2114-4. Epub 2011 Oct 18.

9.

[Effect of neoadjuvant chemotherapy on the results of resection of colorectal liver metastases].

Ivorra P, Sabater L, Calvete J, Camps B, Cervantes A, Bosch A, Plazzotta C, Cassinello N, Arlandis P, Lledó S.

Cir Esp. 2007 Sep;82(3):166-71. Spanish.

10.

Identification of patients likely to benefit from metastasectomy in stage IV colorectal cancer.

Shimomura M, Okajima M, Hinoi T, Egi H, Takakura Y, Kawaguchi Y, Tokunaga M, Adachi T, Tashiro H, Ohdan H.

Int J Colorectal Dis. 2012 Oct;27(10):1339-46. Epub 2012 Mar 10.

PMID:
22407400
11.

Prospective phase II study of neoadjuvant FOLFOX6 plus cetuximab in patients with colorectal cancer and unresectable liver-only metastasis.

Ji JH, Park SH, Lee J, Kim TW, Hong YS, Kim KP, Kim SY, Baek JY, Kang HJ, Shin SJ, Shim BY, Park YS.

Cancer Chemother Pharmacol. 2013 Jul;72(1):223-30. doi: 10.1007/s00280-013-2190-1. Epub 2013 May 21.

PMID:
23689915
12.

Outcome after resection of hepatic and pulmonary metastases of colorectal cancer.

Neeff H, Hörth W, Makowiec F, Fischer E, Imdahl A, Hopt UT, Passlick B.

J Gastrointest Surg. 2009 Oct;13(10):1813-20. doi: 10.1007/s11605-009-0960-1. Epub 2009 Jul 11.

PMID:
19593668
13.

Is the clinical risk score for patients with colorectal liver metastases still useable in the era of effective neoadjuvant chemotherapy?

Ayez N, Lalmahomed ZS, van der Pool AE, Vergouwe Y, van Montfort K, de Jonge J, Eggermont AM, Ijzermans JN, Verhoef C.

Ann Surg Oncol. 2011 Oct;18(10):2757-63. doi: 10.1245/s10434-011-1819-8. Epub 2011 Jun 3.

14.

Response to neoadjuvant chemotherapy does not predict overall survival for patients with synchronous colorectal hepatic metastases.

Gallagher DJ, Zheng J, Capanu M, Haviland D, Paty P, Dematteo RP, D'Angelica M, Fong Y, Jarnagin WR, Allen PJ, Kemeny N.

Ann Surg Oncol. 2009 Jul;16(7):1844-51. doi: 10.1245/s10434-009-0348-1. Epub 2009 Feb 18.

PMID:
19224284
15.

Factors influencing oncological outcomes in patients who develop pulmonary metastases after curative resection of colorectal cancer.

Kim CH, Huh JW, Kim HJ, Lim SW, Song SY, Kim HR, Na KJ, Kim YJ.

Dis Colon Rectum. 2012 Apr;55(4):459-64. doi: 10.1097/DCR.0b013e318246b08d.

PMID:
22426271
16.
17.

Multicenter phase II study of modified FOLFOX6 as neoadjuvant chemotherapy for patients with unresectable liver-only metastases from colorectal cancer in Japan: ROOF study.

Takahashi T, Shibata Y, Tojima Y, Tsuboi K, Sakamoto E, Kunieda K, Matsuoka H, Suzumura K, Sato M, Naganuma T, Sakamoto J, Morita S, Kondo K.

Int J Clin Oncol. 2013 Apr;18(2):335-42. doi: 10.1007/s10147-012-0382-z. Epub 2012 Mar 2.

PMID:
22383023
18.

Tumor progression while on chemotherapy: a contraindication to liver resection for multiple colorectal metastases?

Adam R, Pascal G, Castaing D, Azoulay D, Delvart V, Paule B, Levi F, Bismuth H.

Ann Surg. 2004 Dec;240(6):1052-61; discussion 1061-4.

19.

Liver transplantation in a patient with unresectable colorectal liver metastases -- a case report.

Hrehoreţ D, Alexandrescu S, Braşoveanu V, Grigorie R, Zielinski C, Popescu I.

Chirurgia (Bucur). 2013 Sep-Oct;108(5):719-24.

20.

Selective resection of colorectal liver metastases.

Tamandl D, Gruenberger B, Herberger B, Schoppmann S, Bodingbauer M, Schindl M, Puhalla H, Fleischmann E, Schima W, Jakesz R, Laengle F, Gruenberger T.

Eur J Surg Oncol. 2007 Mar;33(2):174-82. Epub 2006 Oct 12.

PMID:
17046194
Items per page

Supplemental Content

Write to the Help Desk